Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS Framework Agreement for Branded Medicines - National

NHS England

This public procurement record has 2 releases in its history.

Award

27 Oct 2021 at 15:58

Award Notice
Tender

28 May 2021 at 13:26

Tender Notice
Summary of the contracting process

The NHS England is conducting a public procurement process titled "NHS Framework Agreement for Branded Medicines – National." This tender falls under the pharmaceutical products category and involves contracting for goods. The framework period is set from 1 November 2021 to 31 October 2022, with options for extending the contract by up to a total of 12 months at the authority's discretion. The primary procurement method is open, encouraging broad competition. The tender is currently in the award stage, having reached completion status as of the last update on 27 October 2021.

This tender presents significant growth opportunities for businesses in the pharmaceutical sector, particularly those that manufacture or supply branded medicines. Companies of all sizes, including large-scale manufacturers like Pfizer Ltd and smaller suppliers like Morningside Pharmaceuticals, would be well-suited to compete. Engaging with this framework could lead to long-term contracts and beneficial partnerships with NHS bodies and other healthcare providers, enhancing market reach and business viability in the health services sector.

How relevant is this notice?

Notice Information

Notice Title

NHS Framework Agreement for Branded Medicines - National

Notice Description

NHS Framework Agreement for Branded Medicines - National Annual Category Tender and National Tender

Lot Information

CM/PHR/20/5610/01 - NHS Framework Agreement for Branded Medicines - National Cat

CM/PHR/20/5610/01 - NHS Framework Agreement for Branded Medicines - National Category TenderPeriod of framework: 1 November 2021 to 31 October 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

Options: There will be an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

CM/PHR/20/5610/02 - NHS Framework Agreement for Branded Medicines - National Ten

CM/PHR/20/5610/02 - NHS Framework Agreement for Branded Medicines - National TenderPeriod of framework: 1 November 2021 to 30 April 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 18months

Options: There will be an option to extend (at the Authority's discretion) for a period or periods up to a total of 18 months

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-02b648
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/026946-2021
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£309,584,002 £100M-£1B
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
27 Oct 20214 years ago
Submission Deadline
2 Jul 2021Expired
Future Notice Date
Not specified
Award Date
27 Sep 20214 years ago
Contract Period
1 Nov 2021 - 30 Apr 2023 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Additional Buyers

The NHS Commissioning Board (operating under the name of NHS England)

Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
LS2 7UE
Postcode Area
Leeds
Country
England
Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified
Local Authority
Leeds
Electoral Ward
Little London & Woodhouse
Westminster Constituency
Leeds Central and Headingley

Supplier Information

Number of Suppliers
37
Supplier Names

Accord-UK Ltd

Aspen Pharmacare UK Limited

Aspire Pharma Limited

Astellas Pharma Ltd

Aventis Pharma ltd t/a Sanofi

Bayer Ltd

Chiesi Limited

Day Lewis Medical Ltd

Dexcel Pharma Ltd

FLYNN PHARMA LTD

Ferring Pharmaceuticals Ltd

Gedeon Richter UK Ltd

Glenmark Pharmaceuticals Europe Limited

Ipsen

Kent Pharma Ltd

Martindale Pharma

Merck Serono Limited

Morningside Pharmaeuticals

Mylan

Napp Pharmaceuticals Ltd

Nordic Pharma

Novartis Pharmaceuticals UK Ltd

Orifarm UK

Pfizer Ltd

Pharmasure

QDEM PHARMACEUTICALS LIMITED

Ridge Pharma

Sandoz Ltd

Takeda UK Ltd

Tetris Pharma Lts

Teva UK Limited

Theramex HQ UK

Tillomed Laboratories ltd

UL Global Pharma

Wockhardt UK Limited

Zentiva Pharma UK Ltd

medac Pharma LLP

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...